Patents by Inventor Qi Qiao

Qi Qiao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150284394
    Abstract: This application discloses compounds according to generic Formula I wherein all variables are defined as described herein, which inhibit Btk. The compounds disclosed herein are useful to modulate the activity of Btk and treat diseases associated with excessive Btk activity. The compounds are further useful to treat inflammatory and auto immune diseases associated with aberrant B-cell proliferation such as rheumatoid arthritis. Also disclosed are compositions containing compounds of Formula I and at least one carrier, diluent or excipient.
    Type: Application
    Filed: October 23, 2013
    Publication date: October 8, 2015
    Inventors: Niala Bhagirath, Romyr Dominique, Joshua Kennedy-Smith, Francisco Javier Lopez-Tapia, Eric Mertz, Qi Qiao, Sung-Sau So
  • Patent number: 9084094
    Abstract: The present disclosure discloses a method for group-transmitting multimedia messages. The method comprises the following steps: setting addresses of reception parties at a transmission terminal; after a multimedia message is edited by a user, the transmission terminal establishing a connection via Wireless Fidelity (WIFI) with reception terminals according to the addresses of the reception parties, and transmitting the multimedia message to the reception terminals via the established connection according to the addresses of the reception parties. The present disclosure further discloses a device for group-transmitting multimedia messages. The method and the device of the present disclosure realize the group-transmission of multimedia messages without limiting the size of the multimedia messages, thus profiting the development and popularization of the multimedia message service.
    Type: Grant
    Filed: March 17, 2011
    Date of Patent: July 14, 2015
    Assignee: ZTE Corporation
    Inventors: Zhihui Lin, Qi Qiao, Yi Liu
  • Publication number: 20130235787
    Abstract: The present disclosure discloses a method for group-transmitting multimedia messages. The method comprises the following steps: setting addresses of reception parties at a transmission terminal; after a multimedia message is edited by a user, the transmission terminal establishing a connection via Wireless Fidelity (WIFI) with reception terminals according to the addresses of the reception parties, and transmitting the multimedia message to the reception terminals via the established connection according to the addresses of the reception parties. The present disclosure further discloses a device for group-transmitting multimedia messages. The method and the device of the present disclosure realize the group-transmission of multimedia messages without limiting the size of the multimedia messages, thus profiting the development and popularization of the multimedia message service.
    Type: Application
    Filed: March 17, 2011
    Publication date: September 12, 2013
    Applicant: ZTE Corporation
    Inventors: Zhihui Lin, Qi Qiao, Yi Liu
  • Publication number: 20130115940
    Abstract: The present invention discloses a method and an apparatus of downloading files based on wireless fidelity WIFI. The method comprises: setting a download task, searching an access point for accessing the network; and judging whether the found access point is a WIFI access point; if it is a WIFI access point, then downloading a file indicated by the download task. With the present invention, when a user departs the coverage area of current WIFI access point or the current WIFI access point fails, the system can automatically store the unfinished download task and continuously search a WIFI access point and continue to download the file indicated by the stored download task according to a preset condition after accessing a WIFI access point, thus overcoming the problem that there is limit in using WIFI to download files in the related art, simplifying user operation, and improving user experience.
    Type: Application
    Filed: October 12, 2010
    Publication date: May 9, 2013
    Inventors: Kai Zhou, Qi Qiao
  • Publication number: 20120184548
    Abstract: Compounds of formula and pharmaceutically acceptable salts thereof are described, as well as the pharmaceutical compositions containing said compounds and their pharmaceutically acceptable salts, and the use of said compounds and pharmaceutical compositions for the treatment, control or amelioration of proliferative diseases, including cancer.
    Type: Application
    Filed: January 11, 2012
    Publication date: July 19, 2012
    Inventors: Romyr Dominique, Kin-Chun Luk, Qi Qiao, Pamela Loreen Rossman
  • Patent number: 8105863
    Abstract: This invention discloses a method for etching a see-through thin film solar module, comprising: printing ink paste which resists the etching of etching solutions in the protected area of the thin film solar module which is placed under a screen; drying and solidifying the ink paste; coating etching solutions on the thin film solar module; and removing the ink paste. The method of this invention can accurately position the see-through area, achieve various selections of see-through patterns, facilitate the realization of the see-through function in large-area thin film solar modules, and alleviate the problem that a short circuit easily occurs in a see-through thin film solar module.
    Type: Grant
    Filed: July 8, 2010
    Date of Patent: January 31, 2012
    Assignees: Wuxi Suntech Power Co., Ltd., Suntech Power Co., Ltd.
    Inventors: Peng Guo, Xianzhong Song, Qi Qiao, Yongqian Wang
  • Patent number: 8093385
    Abstract: Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, COPD.
    Type: Grant
    Filed: July 28, 2008
    Date of Patent: January 10, 2012
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Romyr Dominique, Nader Fotouhi, Paul Gillespie, Robert Alan Goodnow, Agnieszka Kowalczyk, Qi Qiao, Achyutharao Sidduri
  • Patent number: 8093253
    Abstract: Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, COPD.
    Type: Grant
    Filed: February 23, 2009
    Date of Patent: January 10, 2012
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Romyr Dominique, Robert Alan Goodnow, Jr., Agnieszka Kowalczyk, Jianping Lou, Qi Qiao, Achyutharao Sidduri, Jefferson Wright Tilley
  • Patent number: 8088936
    Abstract: Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, COPD.
    Type: Grant
    Filed: March 10, 2010
    Date of Patent: January 3, 2012
    Assignee: Hoffman-La Roche Inc.
    Inventors: Romyr Dominique, Robert Alan Goodnow, Jr., Agnieszka Kowalczyk, Qi Qiao, Achyutharao Sidduri, Jefferson Wright Tilley
  • Patent number: 7989454
    Abstract: Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, COPD.
    Type: Grant
    Filed: December 2, 2008
    Date of Patent: August 2, 2011
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Romyr Dominique, Robert Alan Goodnow, Jr., Agnieszka Kowalczyk, Qi Qiao, Achyutharao Sidduri, Jefferson Wright Tilley
  • Publication number: 20110008928
    Abstract: This invention discloses a method for etching a see-through thin film solar module, comprising: printing ink paste which resists the etching of etching solutions in the protected area of the thin film solar module which is placed under a screen; drying and solidifying the ink paste; coating etching solutions on the thin film solar module; and removing the ink paste. The method of this invention can accurately position the see-through area, achieve various selections of see-through patterns, facilitate the realization of the see-through function in large-area thin film solar modules, and alleviate the problem that a short circuit easily occurs in a see-through thin film solar module.
    Type: Application
    Filed: July 8, 2010
    Publication date: January 13, 2011
    Applicants: WUXI SUNTECH POWER CO., LTD., SUNTECH POWER CO., LTD.
    Inventors: Peng Guo, Xianzhong Song, Qi Qiao, Yongqian Wang
  • Publication number: 20100240678
    Abstract: Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification.
    Type: Application
    Filed: March 10, 2010
    Publication date: September 23, 2010
    Inventors: Romyr Dominique, Robert Alan Goodnow, JR., Agnieszka Kowalczyk, Qi Qiao, Achyutharao Sidduri, Jefferson Wright Tilley
  • Patent number: 7625895
    Abstract: and the pharmaceutically acceptable salts and esters thereof, X, R1, R2, Y1 and Y2 are described herein inhibit the interaction of MDM2 protein with a p53-like peptide and hence have anti proliferative activity.
    Type: Grant
    Filed: March 18, 2008
    Date of Patent: December 1, 2009
    Assignee: Hoffmann-Le Roche Inc.
    Inventors: Romyr Dominique, Robert Alan Goodnow, Jr., Qi Qiao, Binh Thanh Vu
  • Publication number: 20090253684
    Abstract: Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, COPD.
    Type: Application
    Filed: December 2, 2008
    Publication date: October 8, 2009
    Inventors: Romyr Dominique, Robert Alan Goodnow, JR., Agnieszka Kowalczyk, Qi Qiao, Achyutharao Sidduri, Jefferson Wright Tilley
  • Publication number: 20090227603
    Abstract: Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification.
    Type: Application
    Filed: February 23, 2009
    Publication date: September 10, 2009
    Inventors: Romyr Dominique, Robert Alan Goodnow, JR., Agnieszka Kowalczyk, Jianping Lou, Qi Qiao, Achyutharao Siddurl, Jefferson Wright Tilley
  • Publication number: 20090054466
    Abstract: Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification.
    Type: Application
    Filed: July 28, 2008
    Publication date: February 26, 2009
    Inventors: Romyr Dominique, Nader Fotouhi, Paul Gillespie, Robert Alan Goodnow, Agnieszka Kowalczyk, Qi Qiao, Achyutharao Sidduri
  • Publication number: 20080255119
    Abstract: and the pharmaceutically acceptable salts and esters thereof X, R1, R2, Y1 and Y2 are described herein inhibit the interaction of MDM2 protein with a p53-like peptide and hence have anti proliferative activity.
    Type: Application
    Filed: March 18, 2008
    Publication date: October 16, 2008
    Inventors: Romyr Dominique, Robert Alan Goodnow, Qi Qiao, Binh Thanh Vu
  • Patent number: 6458816
    Abstract: The present invention relates to compounds according to the structure: Where R is H or CH3; R2 is phosphate which can be free acid or salt; R3 is H, F, Cl, Br, I, OCH3, OCF3 , CF3 or a C1-C3 alkyl group; R4 is H, F, Cl, Br, I, OCH3, OCF3 or CF3; and R5 and R6 are each independently H, F, Cl, Br, I, OCH3, OCF3 or CF3, with the proviso that when any two of R3, R4, R5 or R6 are other than H, the other two of R3, R4, R5 or R6 are H which may be used to treat neoplasia, including cancer.
    Type: Grant
    Filed: October 15, 2001
    Date of Patent: October 1, 2002
    Assignee: Vion Pharmaceuticals, Inc.
    Inventors: Terrence W. Doyle, Srinivasa Karra, Zujin Li, Xu Lin, John Mao, Qi Qiao, Yang Xu
  • Publication number: 20020119955
    Abstract: The present invention relates to compounds according to the structure: 1
    Type: Application
    Filed: October 15, 2001
    Publication date: August 29, 2002
    Inventors: Terrence W. Doyle, Srinivasa Karra, Zujin Li, Xu Lin, John Mao, Qi Qiao, Yang Xu
  • Patent number: 6251893
    Abstract: Described herein are compounds with affinity for the 5-HT6 receptor, which have the general formula: wherein R1, R2, R3 and R4 are independently selected from the group consisting of H, halo, OH, C1-6alkyl, C1-6alkoxy, C2-6alkenyl, C2-6alkynyl, C3-7cycloalkyl and others; R5 is selected from the group consisting of SO2Ar, C(O)Ar, Ar and CH2Ar; R6 and R7 are independently selected from the group consisting of H, C1-6alkyl, optionally substituted phenyl and optionally substituted benzyl; ————— represents a single or double bond; n is selected from an integer of from 1-3; X is selected from the group consisting of CR17 and N; Z is selected from the group consisting of C, CH and N, provided that when ————— is a double bond, Z is C and when ————— is a single bond, Z is selected from CH and N; Ar is an optionally substituted aromatic group selected from the group consisting of phenyl, pyridyl, thienyl,
    Type: Grant
    Filed: September 18, 1998
    Date of Patent: June 26, 2001
    Assignee: NPS Allelix Corp.
    Inventors: Shawn Maddaford, Tao Xin, Abdelmalik Slassi, Ashok Tehim, Qi Qiao